The Goldman Sachs Group Trims Omega Therapeutics (NASDAQ:OMGA) Target Price to $4.00

Omega Therapeutics (NASDAQ:OMGA – Get Rating) had its price target reduced by investment analysts at The Goldman Sachs Group from $7.00 to $4.00 in a report issued on Tuesday, Stock Target Advisor reports. The brokerage presently has a “neutral” rating on the stock. The Goldman Sachs Group’s price objective points to a potential upside of […]

Related Keywords

Piper Sandler ,Omega Therapeutics Inc ,Geode Capital Management ,Zacks Investment Research ,Goldman Sachs Group ,Harbourvest Partners ,Blackrock Inc ,Deutsche Bank ,Omega Therapeutics ,Get Rating ,Stock Target Advisor ,Capital Management ,Target Advisor ,Nasdaq Omga ,Komga ,Medical ,Lower Price Target ,The Goldman Sachs Group Inc ,